Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (151-160 of 253) with videos related to

Pageof 26
Sort By:
Acta Neuropathologica|June 10, 2020
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Acta Neuropathologica|August 20, 2016
Evidence of H3 K27M mutations in posterior fossa ependymomasMarco Gessi, David Capper, Felix Sahm, et al.
Neuro-Oncology|September 27, 2008
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapyStefan Rutkowski, Nicolas Ulrich Gerber, Katja von Hoff, et al.
Acta Neuropathologica|December 3, 2011
Molecular subgroups of medulloblastoma: the current consensusMichael D Taylor, Paul A Northcott, Andrey Korshunov, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Neuro-Oncology|April 5, 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatmentDenise Obrecht-Sturm, Lena Schömig, Martin Mynarek, et al.
Acta Neuropathologica|December 3, 2016
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor TaxonomyDavid N Louis, Ken Aldape, Daniel J Brat, et al.
Acta Neuropathologica|May 15, 2013
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arraysVolker Hovestadt, Marc Remke, Marcel Kool, et al.
Plos One|January 24, 2020
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatmentHolger Ottensmeier, Paul G Schlegel, Matthias Eyrich, et al.
Journal of Neuro-Oncology|December 12, 2012
Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groupsMartin Benesch, André O von Bueren, Tobias Dantonello, et al.
Pageof 26

Showing results (151-160 of 253) with videos related to

Sort By:
Pageof 26
Acta Neuropathologica|June 10, 2020
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Acta Neuropathologica|August 20, 2016
Evidence of H3 K27M mutations in posterior fossa ependymomasMarco Gessi, David Capper, Felix Sahm, et al.
Neuro-Oncology|September 27, 2008
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapyStefan Rutkowski, Nicolas Ulrich Gerber, Katja von Hoff, et al.
Acta Neuropathologica|December 3, 2011
Molecular subgroups of medulloblastoma: the current consensusMichael D Taylor, Paul A Northcott, Andrey Korshunov, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Neuro-Oncology|April 5, 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatmentDenise Obrecht-Sturm, Lena Schömig, Martin Mynarek, et al.
Acta Neuropathologica|December 3, 2016
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor TaxonomyDavid N Louis, Ken Aldape, Daniel J Brat, et al.
Acta Neuropathologica|May 15, 2013
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arraysVolker Hovestadt, Marc Remke, Marcel Kool, et al.
Plos One|January 24, 2020
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatmentHolger Ottensmeier, Paul G Schlegel, Matthias Eyrich, et al.
Journal of Neuro-Oncology|December 12, 2012
Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groupsMartin Benesch, André O von Bueren, Tobias Dantonello, et al.
Pageof 26